Business Context and Reporting Period
This Form 8-K is a current report filed by Hancock Jaffe Laboratories, Inc. (not Envveno Medical Corp as indicated in metadata) on March 30, 2020. The registrant is incorporated in Delaware and trades on The NASDAQ Stock Market LLC under the symbols HJLI (Common Stock) and HJLIW (Warrants). The company is designated as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
The primary material change reported is the departure of a senior executive:
- Robert Rankin resigned from his positions as Chief Financial Officer, Secretary, and Treasurer effective March 30, 2020.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The report is limited to the notification of the officer's resignation.
Investor Verification Checklist
- Verify the appointment of a new Chief Financial Officer, Secretary, and Treasurer to replace Robert Rankin.
- Confirm the reason for the resignation and whether it was voluntary or related to any undisclosed issues.
- Review subsequent filings for any impact on the company's financial reporting or internal controls.